KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Shares Outstanding (Weighted Average) (2016 - 2025)

Sarepta Therapeutics has reported Shares Outstanding (Weighted Average) over the past 15 years, most recently at $100.1 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $100.1 million for Q4 2025, up 5.31% from a year ago — trailing twelve months through Dec 2025 was $100.1 million (up 5.31% YoY), and the annual figure for FY2025 was $100.1 million, up 5.31%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $100.1 million at Sarepta Therapeutics, roughly flat from $100.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for SRPT hit a ceiling of $100.2 million in Q3 2025 and a floor of $79454.0 in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $88.8 million (2023), compared with a mean of $82.1 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): plummeted 99.9% in 2021 and later soared 109715.74% in 2022.
  • Sarepta Therapeutics' Shares Outstanding (Weighted Average) stood at $81.3 million in 2021, then rose by 7.75% to $87.6 million in 2022, then grew by 5.53% to $92.4 million in 2023, then increased by 2.9% to $95.1 million in 2024, then increased by 5.31% to $100.1 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $100.1 million (Q4 2025), $100.2 million (Q3 2025), and $97.7 million (Q2 2025) per Business Quant data.